Topical Vapocoolant to Reduce Pain With Nexplanon Insertion: A Randomized Controlled Trial
Queen's Medical Center
Summary
The purpose of this study is to assess if Pain Ease vapocoolant spray decreases pain associated with lidocaine injection during Nexplanon insertion procedures.
Description
This study will be for patients in the office having a Nexplanon (etonogestrel implant) insertion. The doctor in clinic will evaluate if a patient meets eligibility criteria for this study. If the patient meets eligibility criteria, the doctor will inform the patient of the study and the potential risks. If patients elect to participate, a research coordinator will obtain written informed consent. The patient will be randomized (patient is blinded) to receive either Pain Ease vapocoolant spray or placebo (normal saline) spray. They will receive the spray just before lidocaine injection during…
Eligibility
- Age range
- 14+ years
- Sex
- Female
- Healthy volunteers
- Yes
Inclusion Criteria: * At least 14 years or older * Undergoing an etonogestrel implant insertion in the arm in POB1 Suite 1004 or POB2 Suite 402 * English speaking * Able and willing to sign the informed consent form and agree to terms of the study Exclusion Criteria: * Required or requested narcotics, anxiolytics, IV sedation, or general anesthesia for the procedure * Known previous exposure to vapocoolant spray * Nexplanon removal and reinsertion same day during visit in the same arm * Contraindications to vapocoolant spray components (ethyl chloride and 1,1,1,3,3-pentafluoropropane/1,1,1,…
Interventions
- DeviceVapocoolant spray
Pain Ease will be used per manufacturer instruction, applying the spray for 5 seconds or until the skin turns white, whichever occurs first.
- OtherPlacebo
Nature's Tears will be applied to the arm as a placebo spray
Locations (3)
- Queens Medical Center POB 2 Suite 402Honolulu, Hawaii
- Queens Medical Center POB1 Clinic 1004Honolulu, Hawaii
- Women's Center Queen's North Hawai'i Community Hospital Suite #124 and #120Waimea, Hawaii